Nuvalent (NUVL) EBT (2020 - 2026)

Nuvalent (NUVL) has 7 years of EBT data on file, last reported at -$109.1 million in Q1 2026.

• Quarterly EBT fell 29.24% year-over-year to -$109.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$449.5 million (down 49.67% YoY) and the FY2025 annual result came in at -$424.8 million, down 63.39% from the prior year.
• EBT grew to -$109.1 million in Q1 2026, from -$118.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$18.6 million in Q1 2022 to a low of -$122.3 million in Q3 2025.
• A 5-year average of -$59.2 million and a median of -$44.1 million in 2024 frame the typical range for EBT.
• The widest YoY moves for EBT: up 32.65% in 2022, down 201.38% in 2022.
• Tracing NUVL's EBT over 5 years: stood at -$27.5 million in 2022, then sank by 39.44% to -$38.3 million in 2023, then tumbled by 94.8% to -$74.6 million in 2024, then plunged by 58.94% to -$118.6 million in 2025, then climbed by 7.97% to -$109.1 million in 2026.
• The last three EBT figures came in at -$109.1 million (Q1 2026), -$118.6 million (Q4 2025), and -$122.3 million (Q3 2025), per Business Quant data.